Skip to content
    Pfizer Ventures logo

    Pfizer Ventures

    New York, New York, United StatesFounded 2004
    www.pfizer.com/about/partners/venture-investments
    Biotech & Life SciencesHealthcare

    Pfizer Ventures is the strategic corporate venture capital arm of Pfizer Inc., founded in 2004. It invests globally in innovative biopharmaceutical companies advancing breakthrough medicines, platform technologies, and other healthcare technologies of current or future strategic interest to Pfizer.

    55% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $61.3M (across 100 rounds with reported amounts).

    Find people at Pfizer Ventures on Goldilocks AI

    Portfolio

    83

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    11

    Team

    Michael C. Diem, MD

    Michael C. Diem, MD

    Vice President, WWBD / Senior Managing Partner

    Anthony Barry, PhD

    Anthony Barry, PhD

    Executive Director, WWBD / Partner

    Christopher O’Donnell, PhD

    Christopher O’Donnell, PhD

    Vice President, WWBD / Partner

    Irena Melnikova, PhD

    Irena Melnikova, PhD

    Executive Director, WWBD / Partner

    Marie-Claire Peakman, MRCPharm, PhD

    Marie-Claire Peakman, MRCPharm, PhD

    Executive Director, WWBD / Partner

    Rana Al-Hallaq, PhD

    Rana Al-Hallaq, PhD

    Vice President, WWBD / Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    116 investments
    CompanyRoundAmountDate
    CellCentric logoCellCentricSeries D$220MMay 2026
    CCrossbowSeries B—Mar 2026
    TTRexBio, Inc.Series C$50MJan 2026
    Vibrant Therapeutics logoVibrant TherapeuticsSeries C$61MJan 2026
    Trex Bio logoTrex BioUnknown$50MJan 2026
    FoRx Therapeutics logoFoRx TherapeuticsSeries A$50MDec 2025
    TRIANA Biomedicines logoTRIANA BiomedicinesSeries B$120MDec 2025
    Artios Pharma logoArtios PharmaSeries D$115MNov 2025
    AArtiosSeries D$115MNov 2025
    Mission Therapeutics logoMission TherapeuticsUnknown$13.3MOct 2025
    Cartography Biosciences logoCartography BiosciencesSeries B$67MOct 2025
    OTR Therapeutics logoOTR TherapeuticsSeries A$100MJun 2025
    TRIMTECH Therapeutics logoTRIMTECH TherapeuticsSeed$14MMar 2025
    MindImmune Therapeutics logoMindImmune TherapeuticsSeries A$30MJan 2025
    Promise Bio logoPromise BioSeed$8.3MDec 2024
    ImmunOS logoImmunOSUnknown$11MSep 2024
    ImmunOs logoImmunOsSeries C$11MSep 2024
    Autobahn Therapeutics logoAutobahn TherapeuticsSeries C$100MJul 2024
    Autobahn logoAutobahnSeries C$100MJul 2024
    GGrey Wolf TherapeuticsSeries B$50MMay 2024
    Greywolf Therapeutics logoGreywolf TherapeuticsSeries B$50MMay 2024
    Curve Therapeutics logoCurve TherapeuticsSeries A$51.4MFeb 2024
    COUR Pharmaceuticals logoCOUR PharmaceuticalsSeries A$105MJan 2024
    CCrossbow Therapeutics, Inc.Series A$80MJul 2023
    Promise Bio logoPromise BioSeed$8.3MApr 2023
    Page 1 of 5

    Top Co-Investors

    Sofinnova Partners23 shared
    M Ventures17 shared
    Alexandria Venture Investments16 shared
    RA Capital Management15 shared
    SV Health Investors13 shared
    Andera Partners12 shared
    IP Group plc11 shared
    The Invus Group, LLC11 shared
    Eli Lilly and Company11 shared
    Omega Funds9 shared
    Cormorant Asset Management9 shared
    EQT Life Sciences8 shared
    Atlas Venture8 shared
    SR One8 shared
    Samsara BioCapital7 shared
    Arix Bioscience7 shared
    Bristol Myers Squibb7 shared
    Polaris Partners7 shared
    AbbVie7 shared
    Canaan Partners7 shared

    Last updated: 7 September 2026